Background Adding ezetimibe to high-intensity statin therapy is used for additional lowering
of low-density lipoprotein cholesterol (LDL-C); however, there are little data on the efficacy of …

Objective: To review and analyse the evidence for the cholesterol-lowering effect of
ezetimibe in adult patients with hypercholesterolaemia who are not at low-density …

Objective: To systematically review and analyse evidence for cholesterol-lowering efficacy of
at least 4 weeks of add-on ezetimibe vs doubling statin dose, in adults with primary …

Introduction Patients with atherosclerotic cardiovascular disease (ASCVD), especially those
with recent (< 1 year) acute coronary syndrome (ACS), are at high risk for recurrent …

Background Statins are the hypolipemic treatment of choice for hyperlipidemia with
confirmed atherosclerotic cardiovascular disease (ASCVD) protective effect, proven even in …

Ezetimibe is widely used in combination with statins to reduce low‐density lipoprotein. We
sought to examine the impact of ezetimibe when added to statins on patient‐important …

Although ezetimibe has potential value as an add-on therapy to statins, it is not established
whether the addition of ezetimibe to statin therapy is more effective than double-dose statin …

Background Reducing low-density lipoprotein cholesterol (LDL-C) is associated with
reduced risk for major coronary events. Despite statin efficacy, a considerable proportion of …

Background and objective: Elevated serum low-density lipoprotein cholesterol (LDL-C) is a
major cardiovascular risk factor. This study aimed to determine the efficacy and safety of co …

Background The addition of ezetimibe to statin therapy has been widely demonstrated to
significantly reduce low-density lipoprotein cholesterol levels. However, the efficacy of …